Your session is about to expire
← Back to Search
iParent2Parent Support Program for Kidney Transplant Parents
N/A
Recruiting
Led By Samantha J. Anthony, PhD, MSW
Research Sponsored by The Hospital for Sick Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to program completion, an average of one year
Awards & highlights
No Placebo-Only Group
Summary
This trial will connect parents of pediatric kidney transplant recipients to offer peer support and mentorship, improving mental health & long-term patient health.
Who is the study for?
This trial is for parents of children under 18 who had a kidney transplant at least two months ago, or under 21 if they're one year post-transplant. They need to speak English and have access to WhatsApp on a device. To be mentors, they must be recommended by their child's healthcare team.
What is being tested?
The iParent2Parent (iP2P) program is being tested. It's an online mentorship where parents of pediatric kidney transplant recipients give each other support. Participants are randomly chosen to either join iP2P or a control group without this peer support.
What are the potential side effects?
Since the intervention involves social support and not medical treatment, there aren't typical side effects like with drugs or surgery. However, participants may experience emotional impacts from sharing experiences.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to program completion, an average of one year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to program completion, an average of one year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Acceptability (Mentees)
Acceptability (Mentors)
Adherence with the iParent2Parent program
+5 moreSecondary study objectives
Coping (Mentees and Mentors)
Family Functioning (Mentees and Mentors)
Parenting stress (Mentees and Mentors)
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: iParent2Parent ProgramExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
iParent2Parent Program
2019
N/A
~10
Find a Location
Who is running the clinical trial?
The Hospital for Sick ChildrenLead Sponsor
710 Previous Clinical Trials
6,958,130 Total Patients Enrolled
Samantha J. Anthony, PhD, MSWPrincipal InvestigatorThe Hospital for Sick Children
1 Previous Clinical Trials
55 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a parent of a child who had a kidney transplant over two months ago, have a device for WhatsApp, and speak English.I am a parent of a child who had a kidney transplant over a year ago, nominated as a mentor, have access to WhatsApp, and speak English.
Research Study Groups:
This trial has the following groups:- Group 1: iParent2Parent Program
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger